BrightAccountsProduction v1.0.0 v1.0.0 2023-09-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts FRS 105 Accounts The principal activity of the business is the development and provision of fertility treatments. 5 March 2025 1 1 NI626434 2024-08-31 NI626434 2023-08-31 NI626434 2022-08-31 NI626434 2023-09-01 2024-08-31 NI626434 2022-09-01 2023-08-31 NI626434 uk-bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 NI626434 uk-curr:PoundSterling 2023-09-01 2024-08-31 NI626434 uk-bus:AbridgedAccounts 2023-09-01 2024-08-31 NI626434 uk-core:CapitalReserve 2024-08-31 NI626434 uk-core:CapitalReserve 2023-08-31 NI626434 2023-09-01 2024-08-31 NI626434 uk-bus:Director1 2023-09-01 2024-08-31 NI626434 uk-bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 NI626434 uk-bus:Micro-entities 2023-09-01 2024-08-31 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
 
 
 
 
 
 
 
 
Intl Embryology Locums Ltd
 
Unaudited Financial Statements
 
for the financial year ended 31 August 2024



Intl Embryology Locums Ltd
Company Registration Number: NI626434
BALANCE SHEET
as at 31 August 2024

    2024   2023
  £   £
 
 
Current assets 26,563   28,563
 
Creditors: amounts falling due within one year (15,217)   (15,857)
  ─────────   ─────────
Net Current Assets 11,346   12,706
  ─────────   ─────────
 
Total Assets less Current Liabilities 11,346   12,706
 
Accruals and deferred income (500)   (500)
  ─────────   ─────────
Net Assets 10,846   12,206
  ═════════   ═════════
 
Capital and Reserves 10,846   12,206
  ═════════   ═════════
 
Notes to the Financial statements
   
1. General Information
 
Intl Embryology Locums Ltd is a private company limited by shares incorporated in Northern Ireland. 303 Park Avenue, 12 Bankmore Street, Belfast, Co. Antrim, BT7 1AQ, Northern Ireland is the registered office, which is also the principal place of business of the company. The nature of the company’s operations and its principal activities are set out in the Director's Report.

The financial statements cover the individual entity Intl Embryology Locums Ltd, for the year ended 31 August 2024.

The company registration number is NI626434.

The financial statements have been presented in Pound (£) which is also the functional currency of the company.
       
2. Employees
 
The average monthly number of employees, including director, during the financial year was
 
  2024 2023
  Number Number
 
Director 1 1
  ═════════ ═════════
   
3. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial year-end.
     
For the financial year ended 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
 
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
 
The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
 
These financial statements have been prepared in accordance with the provisions available to micro-entities in Part 15 of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
 
The company has taken advantage of the exemption under section 444 not to file the Abridged Profit and Loss Account.
 
Approved by the Director on 5 March 2025 and signed by:
 
 
   
________________________________  
David Jennings  
Director